Lightnews — Scholar-powered news

Reposted by Naomi Hannaway

angelikaza.bsky.social @angelikaza.bsky.social · Aug 8

Great to see this published @movedisorder.bsky.social movementdisorders.onlinelibrary.wiley.com/doi/10.1002/...: We found that DTI-ALPS (a proposed indirect proxy for glymphatic clearance) is lower in Parkinson's patients who progress to poor cognitive outcomes, and correlates with cognition. 1/2

Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space (DTI‐ALPS), is Linked to Poor Cognitive Outcomes in Parkinson's Disease

Background Impaired glymphatic clearance may contribute to pathological accumulations in Parkinson's (PD), but how it interacts with other processes causing dementia remains unclear. Diffusion tenso...

movementdisorders.onlinelibrary.wiley.com

1 2 3

Reposted by Naomi Hannaway

Dementia Researcher @dementiaresearcher.bsky.social · Jun 30

Join Dr Angeliki Zarkali’s team at UCL Dementia Research Centre to support neuroimaging and clinical research into Parkinson’s and Lewy Body Dementia. Closing date: 10th July

www.dementiaresearcher.nihr.ac.uk/job/research...

Research Assistant: Clinical Research - DEMENTIA RESEARCHER

Join Dr Angeliki Zarkali’s team at UCL Dementia Research Centre to support neuroimaging and clinical research into Parkinson’s and Lewy Body Dementia.

www.dementiaresearcher.nihr.ac.uk

2 2

Reposted by Naomi Hannaway

Ivelina Dobreva @ivelinadobreva.bsky.social · Jun 20

Pleased to share our new work. Black communities face higher Parkinson’s disease burden, but we know they remain underrepresented in research.
We highlight the key barriers - distrust, stigma, and accessibility - and offer community-driven recommendations to increasing research engagement.

Sage Journals: Discover world-class research

Subscription and open access journals from Sage, the world's leading independent academic publisher.

journals.sagepub.com

1 2 2

Naomi Hannaway @naomihannaway.bsky.social · May 23

Thanks so much to brilliant co-authors @angelikaza.bsky.social, @rimonaweil.bsky.social, Rohan Bhome, @ivelinadobreva.bsky.social, George Thomas,
@ajh1269.bsky.social, Henrik Zetterberg, Irene Gorostiaga Belio & Katie Tucker for your help with this work!

1 3

Naomi Hannaway @naomihannaway.bsky.social · May 23

Our findings suggest that there are differences in underlying processes between dementia with Lewy bodies and Parkinson's dementia, which are distinct from those driving dementia

1 1

Naomi Hannaway @naomihannaway.bsky.social · May 23

Using fixel-based analysis, we showed white matter changes in LBD relative to PD. We also found changes in fibre density of the WM, which were worse in PDD compared to DLB.

1 1

Naomi Hannaway @naomihannaway.bsky.social · May 23

Both plasma p-tau217 and NFL were increased in LBD compared to PD at low risk of dementia and controls, but neither plasma marker showed differences between PDD and DLB

1 1

Naomi Hannaway @naomihannaway.bsky.social · May 23

We measured plasma p-tau217 & NfL and diffusion MRI in 47 DLB, 21 PDD, 29 PD, and 23 controls

1

Naomi Hannaway @naomihannaway.bsky.social · May 23

Really pleased to share our new paper in @alzdemjournals.bsky.social. We compared plasma biomarkers and diffusion MRI between DLB, PDD and PD – to our knowledge this is the first report of plasma p-tau217 concentrations in LBD and PD! dx.doi.org/10.1002/alz....

Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes

INTRODUCTION Despite ongoing debate about whether Parkinson's disease (PD) dementia (PDD) and dementia with Lewy bodies (DLB) are separable diseases or a single Lewy body dementia (LBD) spectrum, th...

dx.doi.org

1 1 6

Reposted by Naomi Hannaway

Nature Biotechnology @natbiotech.nature.com · May 2

The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson’s disease go.nature.com/44TCQ6u

The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson’s disease - Nature Biotechnology

Patients with Parkinson’s disease treated with fetal tissue are assessed 3 years after surgery.

go.nature.com

2 4 5

Reposted by Naomi Hannaway

angelikaza.bsky.social @angelikaza.bsky.social · Feb 26

Thank you so much to @braincomms.bsky.social for highlighting our work! TLDR: white matter maters - do read the paper for more! And thank you to all amazing co-authors without whom this project would not have been possible (amongst them on bluesky: @naomihannaway.bsky.social @rimonaweil.bsky.social)

Brain Communications @braincomms.bsky.social · Feb 26

We're delighted to congratulate the winner of the ECR Paper Prize, Angelika Zarkali! This award is presented to the first author of an outstanding study published in Brain Communications over the past year.
Read more about the winning paper here:https://buff.ly/4idIsvN @angelikaza.bsky.social 🎉

1 2 3

Naomi Hannaway @naomihannaway.bsky.social · Nov 21

Please could I be added as well?

1 1 1

Reposted by Naomi Hannaway

James Catterson @scotsfriction.bsky.social · Nov 21

🧠 130 people now in this UK Dementia Starter Pack! 🧠
📈 (50 more than 2 days ago!) 📈

A great mix of Profs/PIs/Post-docs/PhDs/Technicians.

Please re-post so it can reach a wider audience as I'm sure there are more of us out there ☺️🦋
go.bsky.app/S6FfsTp

7 28 37